These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19476987)

  • 1. Synuclein-gamma (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma.
    Morgan J; Hoekstra AV; Chapman-Davis E; Hardt JL; Kim JJ; Buttin BM
    Gynecol Oncol; 2009 Aug; 114(2):293-8. PubMed ID: 19476987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of synuclein gamma inhibits the movability of endometrial carcinoma cells by PI3K/AKT/ERK signaling pathway.
    Ni M; Zhao Y; Wang X
    Genes Genomics; 2021 Jun; 43(6):633-641. PubMed ID: 33788083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.
    Winder AD; Maniar KP; Wei JJ; Liu D; Scholtens DM; Lurain JR; Schink JC; Buttin BM; Filiaci VL; Lankes HA; Ramirez NC; Park K; Singh M; Lieberman RW; Mannel RS; Powell MA; Backes FJ; Mathews CA; Pearl ML; Secord AA; Peace DJ; Mutch DG; Creasman WT; Kim JJ
    Cancer; 2017 Apr; 123(7):1144-1155. PubMed ID: 27926776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma.
    Mhawech-Fauceglia P; Wang D; Syriac S; Godoy H; Dupont N; Liu S; Odunsi K
    Gynecol Oncol; 2012 Jan; 124(1):148-52. PubMed ID: 22015044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
    Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE
    Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. siRNA Targeting of the SNCG Gene Inhibits the Growth of Gastric Carcinoma SGC7901 Cells in vitro and in vivo by Downregulating the Phosphorylation of AKT/ERK.
    Fan C; Liu J; Tian J; Zhang Y; Yan M; Zhu C
    Cytogenet Genome Res; 2018; 154(4):209-216. PubMed ID: 29902801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of 14-3-3σ is predictive of poor prognosis for patients with human uterine papillary serous carcinoma.
    Suzuki F; Nagase S; Suzuki K; Oba E; Hiroki E; Matsuda Y; Akahira J; Nishigori H; Sugiyama T; Otsuki T; Yoshinaga K; Takano T; Niikura H; Ito K; Sasano H; Yaegashi N
    Tohoku J Exp Med; 2013 Nov; 231(3):193-9. PubMed ID: 24201220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.
    Guo J; Shou C; Meng L; Jiang B; Dong B; Yao L; Xie Y; Zhang J; Chen Y; Budman DR; Shi YE
    Int J Cancer; 2007 Sep; 121(6):1296-305. PubMed ID: 17534899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
    Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
    Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of SNCG suppresses the proliferation of lung cancer cells induced by high glucose.
    Fei J; Xiao C; Yang M; Zhou X; Gong P
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma.
    Takemura Y; Ojima H; Oshima G; Shinoda M; Hasegawa Y; Kitago M; Yagi H; Abe Y; Hori S; Fujii-Nishimura Y; Kubota N; Masuda Y; Hibi T; Sakamoto M; Kitagawa Y
    Cancer Med; 2021 Aug; 10(16):5599-5613. PubMed ID: 34245137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trastuzumab with carboplatin/paclitaxel for treatment of advanced stage and recurrent uterine papillary serous carcinoma: A cost-effectiveness analysis.
    Batman S; Bohn J; Weisenberger MW; Hersh A; Bruegl A; Caughey A; Winter W
    Gynecol Oncol; 2021 Jan; 160(1):214-218. PubMed ID: 33393480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher sensitivity to patupilone versus paclitaxel chemotherapy in primary uterine serous papillary carcinoma cell lines with high versus low HER-2/neu expression in vitro.
    Paik D; Cocco E; Bellone S; Casagrande F; Bellone M; Siegel EE; Richter CE; Schwartz PE; Rutherford TJ; Santin AD
    Gynecol Oncol; 2010 Oct; 119(1):140-5. PubMed ID: 20673976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of synuclein-gamma expression increases the sensitivity of breast cancer cells to paclitaxel treatment.
    Zhou Y; Inaba S; Liu J
    Int J Oncol; 2006 Jul; 29(1):289-95. PubMed ID: 16773211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients.
    Min L; Zhang C; Ma R; Li X; Yuan H; Li Y; Chen R; Liu C; Guo J; Qu L; Shou C
    BMC Cancer; 2016 Sep; 16(1):717. PubMed ID: 27595752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubulin-β-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones.
    Roque DM; Bellone S; English DP; Buza N; Cocco E; Gasparrini S; Bortolomai I; Ratner E; Silasi DA; Azodi M; Rutherford TJ; Schwartz PE; Santin AD
    Cancer; 2013 Jul; 119(14):2582-92. PubMed ID: 23585021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform.
    Schaal K; Hirschfeld M; Bronsert P; Füllgraf H; Jäger M; Herde B; Nöthling C; Mayer S; Erbes T; Stickeler E
    Oncotarget; 2015 Sep; 6(26):22553-63. PubMed ID: 26265438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancer.
    Wu K; Huang S; Zhu M; Lu Y; Chen J; Wang Y; Lin Q; Shen W; Zhang S; Zhu J; Shi YE; Weng Z
    Med Oncol; 2013; 30(3):612. PubMed ID: 23696021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of SNCG transfection on the effectiveness of anti-tumor drugs in PC-3 cell lines].
    Chen JL; Wang B; Zhang LR; He BS; Pan YQ; Zeng QD; Jiang HX; Wang SK
    Zhonghua Nan Ke Xue; 2008 Dec; 14(12):1077-82. PubMed ID: 19157226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SNCG shRNA suppressed breast cancer cell xenograft formation and growth in nude mice.
    Shen PH; Fan QX; Li YW; Zhang W; He XK; Wang Z; Zhang YH
    Chin Med J (Engl); 2011 May; 124(10):1524-8. PubMed ID: 21740810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.